Denis Barritault
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 07, 2022
Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration.Patricia Marques Pereira, Dulce Papy-Garcia, Denis Barritault
|Apr 19, 2019
ReGeneraTing Agents (RGTA®): A new option for healing and improving treatment outcomes for traumatic and burn injuries of the hand.Sharifah Ahmad Roohi, Denis Barritault
|Nov 21, 2018
ReGeneraTing Agents (RGTA®) are a new option to improve amputation outcomes in the recovery of severe hand injuries.Roohi Sharifah Ahmad, Denis Barritault
|Mar 10, 2018
Randomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses.Sandrine Jacquet-Guibon, Anne-Gaelle Dupays, Virginie Coudry
|Dec 08, 2016
RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients.Denis Barritault, Marie Gilbert-Sirieix, Kim Lee Rice
Pageof 1
